Marpai, INC 8-K filings

Marpai, Inc. has been granted an extension by Nasdaq to regain compliance with listing requirements, specifically the minimum market value of listed securities.

Marpai Inc. has entered into a securities purchase agreement to sell 910,000 shares of its Class A common stock at $1.65 per share to HillCour Investment Fund, LLC, an entity controlled by its CEO.

Marpai reports preliminary unaudited financial results for 2023, highlighting revenue growth and significant reductions in operating expenses.

Marpai reported preliminary unaudited financial results for the fourth quarter and full year 2023, highlighting revenue growth and significant reductions in operating expenses.

Marpai, Inc. has announced a new three-year client agreement to provide healthcare benefit services to a regional organization in the southeast, expected to bring at least 20,000 households by the end of 2024.

Marpai, Inc. has amended its agreement with AXA, extending payment terms and potentially reducing obligations, while also securing $1.7 million in revenue-based financing from Libertas Funding, LLC.

Marpai, Inc. has appointed John Powers as President and Chief Operating Officer, while also restructuring executive compensation and addressing the departure of the former COO.

Marpai Inc. has entered into a securities purchase agreement to sell 1,322,100 shares of its Class A common stock at $0.9201 per share in a private placement to company insiders.